Zevra Therapeutics
ZVRA
ZVRA
38 hedge funds and large institutions have $14.6M invested in Zevra Therapeutics in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
55% less call options, than puts
Call options by funds: $29K | Put options by funds: $64K
Holders
38
Holding in Top 10
–
Calls
$29K
Puts
$64K
Top Buyers
| 1 | +$128K | |
| 2 | +$125K | |
| 3 | +$122K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$121K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
+$72K |
Top Sellers
| 1 | -$538K | |
| 2 | -$335K | |
| 3 | -$213K | |
| 4 |
JGC
J. Goldman & Co
New York
|
-$160K |
| 5 |
AWA
Arete Wealth Advisors
Chicago,
Illinois
|
-$70.6K |